Press Review
-
UK research highlights hypercuriosity in ADHD and Stanford warns on rapid medication – Press Review 1 October 2025
.
Key Takeaways Top story: UK study reframes hypercuriosity as a unique advantage for ADHD students and professionals. Stanford researchers urge caution on rapid ADHD medication in preschoolers, citing developmental risks. New Zealand announces broader ADHD diagnosis access starting February 2026,…
-
NIH awards $3.6M for ADHD medication prediction and AI tools transform ADHD workflows – Press Review 30 September 2025
.
Key Takeaways On 30 September 2025, this Press Review highlights significant developments in ADHD research and tools, including a $3.6 million NIH grant to predict which children benefit most from specific ADHD medications. Top story: NIH funds a $3.6 million…
-
New Zealand law lets GPs diagnose ADHD and NIH funds childhood brain study – Press Review 29 September 2025
.
Key Takeaways Top story: New Zealand law enables GPs to diagnose ADHD without specialist referral starting February 2026. NIH allocates $3.6 million to study childhood ADHD brain activity and diagnostic patterns. Tech: AI apps gain traction as daily productivity tools…
-
New ADHD lobbying coalition launches and study urges new adult diagnostic criteria – Press Review 28 September 2025
.
Key Takeaways Top story: A national ADHD lobbying alliance has launched, aiming to influence public policy based on current research. A major study urges changes to adult ADHD diagnostic criteria, citing rising misdiagnosis and ongoing medication shortages. AI productivity tools…
-
ADHD meds before behavior therapy in young children and AI tools boost neurodivergent productivity – Press Review 27 September 2025
.
Key Takeaways On 27 September 2025, the Press Review highlights guidance gaps as young children with ADHD are often prescribed medication before recommended behavioral therapy. Many young children with ADHD receive medication before behavioral therapy, diverging from established guidelines. Annie…
-
Swedish study links ADHD medication to lower impulsivity and AI task apps now tailored for ADHD – Press Review 26 September 2025
.
Key Takeaways A Swedish study finds that ADHD medication significantly reduces impulsive behaviors and related crime risks, impacting treatment strategies and daily life. Digital tools and neuroscience research are advancing how ADHD is managed, with new options for support and…
-
AI tools simplify ADHD task management and new genetics research reveals adult symptom layers – Press Review 25 September 2025
.
Key Takeaways Top story: AI productivity tools are making task management simpler for professionals with ADHD. TikTok is helping women recognize ADHD traits and find supportive communities. New genetics research uncovers complex layers of adult ADHD symptoms. ADHD entrepreneurs share…
-
Harvard links prenatal acetaminophen to autism and ADHD risk and experts affirm Tylenol safety – Press Review 24 September 2025
.
Key Takeaways A new Harvard review links prenatal acetaminophen use to increased risks of autism and ADHD, sparking discussion across expert and neurodivergent communities. Notizia principale: The Harvard review ties prenatal acetaminophen exposure to higher autism and ADHD risks. Experts…
-
Most adults with ADHD face sleep disorders and stimulant shortages worsen – Press Review 23 September 2025
.
Key Takeaways 60% of adults with ADHD experience sleep disorders, emphasizing daily energy and focus challenges for the neurodivergent community. On 23 September 2025, this press review details stimulant shortages, advances in workflow systems, and the passing of a prominent…